141 related articles for article (PubMed ID: 18691566)
1. Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.
Ogasawara K; Mashiba S; Hashimoto H; Kojima S; Matsuno S; Takeya M; Uchida K; Yajima J
Clin Chim Acta; 2008 Nov; 397(1-2):42-7. PubMed ID: 18691566
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
3. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study.
Pilz S; Maerz W; Weihrauch G; Sargsyan K; Almer G; Nauck M; Boehm BO; Winkelmann BR; Mangge H;
Clin Chim Acta; 2006 Feb; 364(1-2):251-5. PubMed ID: 16111669
[TBL] [Abstract][Full Text] [Related]
5. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
[TBL] [Abstract][Full Text] [Related]
6. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
7. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
8. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of apolipoprotein M as a biomarker of coronary artery disease.
Su W; Jiao G; Yang C; Ye Y
Clin Biochem; 2009 Mar; 42(4-5):365-70. PubMed ID: 19100249
[TBL] [Abstract][Full Text] [Related]
10. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
Habib SS
J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
[TBL] [Abstract][Full Text] [Related]
11. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients.
Yeo Y; Byun SW; Lee JY; Min WK; Park JS; Kim SB
Am J Nephrol; 2009; 30(3):310-4. PubMed ID: 19546529
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of preheparin serum lipoprotein lipase mass in normocholesterolemic patients with coronary artery disease].
Hitsumoto T; Yoshinaga K; Sakurai T; Aoyagi K; Matsumoto J; Iizuka T; Kaku M; Sugiyama Y; Kanai M; Uchi T; Noike H; Ohsawa H; Watanabe H; Shirai K
J Cardiol; 2002 Jul; 40(1):1-9. PubMed ID: 12166243
[TBL] [Abstract][Full Text] [Related]
15. The complex link between oxidised low-density lipoprotein and unstable angina.
Niccoli G; Mongiardo R; Lanza GA; Ricco A; Burzotta F; Trani C; Mazzari MA; Liuzzo G; Lombardo A; Rebuzzi AG; Holvoet P; Crea F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):387-91. PubMed ID: 17443110
[TBL] [Abstract][Full Text] [Related]
16. Cardiology management improves secondary prevention measures among patients with coronary artery disease.
Ho PM; Masoudi FA; Peterson ED; Grunwald GK; Sales AE; Hammermeister KE; Rumsfeld JS
J Am Coll Cardiol; 2004 May; 43(9):1517-23. PubMed ID: 15120805
[TBL] [Abstract][Full Text] [Related]
17. Optimized automated apolipoprotein A-I assays as markers for coronary artery disease.
Levinson SS; Hobbs GA
Arch Pathol Lab Med; 1997 Jul; 121(7):678-84. PubMed ID: 9240901
[TBL] [Abstract][Full Text] [Related]
18. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
19. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
[TBL] [Abstract][Full Text] [Related]
20. Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease.
Ni M; Zhang XH; Jiang SL; Zhang Y
Am J Cardiol; 2007 Aug; 100(3):455-8. PubMed ID: 17659928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
